Torrent Pharmaceuticals Ltd.

NSE: TORNTPHARM | BSE: 500420 | ISIN: INE685A01028 | Industry: Pharmaceuticals
| Expensive Performer
3531.6000 -34.60 (-0.97%)
NSE Sep 15, 2025 15:31 PM
Volume: 158.7K
 

3531.60
-0.97%
ICICI Securities Limited
ICICI Securities Ltd | Retail Equity Research Q3Y19 results were better than I-direct estimates mainly due to higher US sales, one-off settlement income and better-than-expected EBITDA margins. Revenues grew 38.9% YoY to | 2051 crore (I-direct estimate: | 1948.3 crore) due to consolidation of Unichem, strong US sales and one-off patent related income (| 63 crore) EBITDA margins improved 305 bps YoY to 27.4% YoY (I-direct estimate: 25%), Adjusting for one-offs, margins were at 26.5%...
Torrent Pharmaceutic.. has an average target of 3746.00 from 5 brokers.
More from Torrent Pharmaceuticals Ltd.
Recommended